Skip to main content
MATERNUS-Kliniken AG logo

MATERNUS-Kliniken AG — Investor Relations & Filings

Ticker · MAK ISIN · DE0006044001 LEI · 391200TNERKXPD0TM559 F Human health and social work activities
Open in API
Filings indexed 378 across all filing types
Latest filing 2024-04-26 Report Publication Anno…
Country DE Germany
Listing F MAK

About MATERNUS-Kliniken AG

https://www.maternus.de/

MATERNUS-Kliniken AG is a healthcare provider that operates a network of senior living facilities, nursing homes, and specialized rehabilitation clinics. The company's core business encompasses a range of services for the elderly, including inpatient care, assisted living, and home care. In addition to its senior care segment, the company manages rehabilitation clinics focused on treating patients with various medical conditions. MATERNUS-Kliniken AG also operates associated service companies within the social and healthcare sector.

Recent filings

Filing Released Lang Actions
MATERNUS-Kliniken-Aktiengesellschaft verschiebt die Veroffentlichung des gepruften Jahres- und Konzernabschlusses 2023 / Veroffentlichung noch ungeprufter wesentlicher Finanzkennzahlen
Report Publication Announcement Classification · 99% confidence The document is a news release from MATERNUS-Kliniken AG, dated April 26, 2024. The headline explicitly states that the company is postponing the publication of its audited Annual and Consolidated Financial Statements for 2023 ('verschiebt die Veröffentlichung des geprüften Jahres- und Konzernabschlusses 2023'). Crucially, it then proceeds to release 'still unaudited essential financial figures' ('noch ungeprüfter wesentlicher Finanzkennzahlen') for the year 2023, including revenue and EBITDA figures. This structure—announcing a delay of the full report while simultaneously releasing preliminary key figures—is characteristic of an Earnings Release (ER) or a precursor announcement. Since it provides the key financial highlights (revenue, EBITDA, balance sheet totals) immediately, it fits the definition of an Earnings Release (ER) better than a general Regulatory Filing (RNS) or a Report Publication Announcement (RPA), which typically just announces the future release date without providing the core numbers. The document is not the full 10-K or IR, but the initial release of the period's results.
2024-04-26 German
Maternus-Kliniken AG: Korrektur des erwarteten Konzern-EBITDA fur das Geschaftsjahr 2023
Earnings Release Classification · 100% confidence The document is explicitly labeled as an 'Ad-hoc' release and an 'Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014' (Insider Information according to Article 17 of Regulation (EU) No. 596/2014). It announces a 'Korrektur des erwarteten Konzern-EBITDA für das Geschäftsjahr 2023' (Correction of the expected Group EBITDA for the 2023 fiscal year). This type of immediate, material financial disclosure, often related to preliminary results or guidance changes, fits best under the 'Earnings Release' (ER) category, as it deals with key financial performance indicators (EBITDA) outside of a full annual or interim report. Although it is a correction, the core subject is the periodic financial outlook/result. It is not a full report (10-K or IR), nor is it a transcript (CT) or a management discussion (MDA). Given the nature of correcting preliminary financial results, ER is the most appropriate fit. FY 2023
2024-04-25 German
MATERNUS-Kliniken Aktiengesellschaft Umsatz nach vorlaufigen Zahlen unter der Prognose, EBITDA ubertrifft Prognose
Earnings Release Classification · 100% confidence The document is a short announcement dated March 5, 2024, titled 'MATERNUS-Kliniken Aktiengesellschaft – Umsatz nach vorläufigen Zahlen unter der Prognose, EBITDA übertrifft Prognose' (Revenue below forecast, EBITDA exceeds forecast based on preliminary figures). It explicitly states it is an 'Veröffentlichung von Insiderinformationen nach Art. 17 der Verordnung (EU) Nr. 596/2014' (Publication of inside information according to Art. 17 of Regulation (EU) No. 596/2014). This type of announcement, providing preliminary financial highlights and management commentary outside of a full periodic report (like 10-K or IR), is characteristic of an Earnings Release (ER). Although it mentions preliminary figures, it is the initial release of those results, not a comprehensive report or just an announcement of a report's publication (RPA). FY 2023
2024-03-05 German
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
Audit Report / Information Classification · 95% confidence The document is a formal German regulatory filing concerning the exemption of various subsidiary companies from the requirement to prepare and publish individual financial statements (Anhang and Lagebericht) under Section 264 (3) of the German Commercial Code (HGB). It details that these subsidiaries are included in the consolidated financial statements of the parent company, MATERNUS-Kliniken-Aktiengesellschaft. This is a standard regulatory disclosure document filed with the commercial register (Handelsregister) to satisfy legal compliance requirements. It does not constitute a full annual report, but rather a specific regulatory notice regarding financial reporting exemptions. FY 2022
2024-02-14 German
Maternus-Kliniken AG: Maternus-Kliniken AG von Cyberangriff betroffen
Regulatory Filings Classification · 95% confidence The document is explicitly labeled as an 'Ad-hoc' announcement and states it is a 'Veröffentlichung von Insiderinformationen nach Artikel 17 der Verordnung (EU) Nr. 596/2014' (Publication of inside information according to Article 17 of Regulation (EU) No 596/2014). This type of immediate, material disclosure regarding a significant, non-public event (a cyberattack) that could affect the share price is characteristic of regulatory market communications. Since it is not a full report (10-K, IR), a specific financial event (ER, DIV), or a management change (MANG), and it is a mandatory regulatory disclosure, it best fits the general 'Regulatory Filings' category (RNS) as a catch-all for mandatory, non-standardized announcements, or potentially a specific regulatory filing if one were more appropriate. Given the options, RNS is the most suitable fallback for a general, time-sensitive regulatory disclosure that isn't covered by the other specific codes.
2023-10-17 German
Maternus-Kliniken AG erzielt erste Erfolge aus den Investitionen in die Professionalisierung des Konzerns
Earnings Release Classification · 100% confidence The document text explicitly mentions 'Halbjahresergebnis' (Half-year result) in the headline and throughout the body, detailing revenue, EBITDA, and net results for the first half of 2023. It provides comprehensive financial figures for a period shorter than a year, which aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it is distributed via EQS News, the content itself is the financial report summary, not just an announcement of the report's publication (which would be RPA/RNS). The length (8668 chars) is substantial enough to be the report summary itself, not just a brief announcement. H1 2023
2023-09-15 German

Browse filings by year

30 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.